{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:14:54Z","timestamp":1789971294256,"version":"4.0.1"},"reference-count":41,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2016,2,1]]},"DOI":"10.1586\/14760584.2016.1123097","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T19:44:35Z","timestamp":1448048675000},"page":"153-166","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":41,"title":["Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV\u00ae) in children"],"prefix":"10.1586","volume":"15","author":[{"given":"K","family":"Chokephaibulkit","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Houillon","sequence":"additional","affiliation":[{"name":"Global Medical Affairs, Sanofi Pasteur, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Feroldi","sequence":"additional","affiliation":[{"name":"Clinical Development, Sanofi Pasteur, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bouckenooghe","sequence":"additional","affiliation":[{"name":"Asia Regional Medical Affairs and Clinical Development, Sanofi Pasteur, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,12,9]]},"reference":[{"key":"CIT0001","unstructured":"Papers of special note have been highlighted as:"},{"key":"CIT0002","unstructured":"\u2022 of interest"},{"key":"CIT0003","unstructured":"\u2022\u2022 of considerable interest"},{"key":"CIT0004","volume-title":"Vaccines","author":"Halstead SB","year":"2008","edition":"5"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00825-11"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.10.085233"},{"key":"CIT0007","first-page":"337","volume":"73","author":"World Health Organization","year":"1998","journal-title":"Wkly Epidemiol Rec"},{"key":"CIT0008","first-page":"69","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.02.006"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003030"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7883\/yoken.JJID.2008.333","volume":"61","author":"Arai S","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.12-0196"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.083"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198809083191004"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.139"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","volume":"73","author":"Chambers TJ","year":"1999","journal-title":"J Virol"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9695"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.4.1742-1751.2000"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00487-3"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.098"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1086\/378356"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00457-1"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.75.659"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.11.12854"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.12.13057"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.005"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.035"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.085"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181f68e9c"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20071"},{"key":"CIT0031","unstructured":"Feroldi E, Thisyakorn U, Pancharoen C, et al. Persistence of antibodies two years after a single injection of live attenuated Japanese encephalitis chimeric virus vaccine at 12-24 months of age. Presented at 7th World Congress of the World Society for Pediatric Infectious Diseases (WSPID); 2011 Nov 16\u201319; Melbourne, Australia"},{"key":"CIT0032","unstructured":"Feroldi E, Kosalaraksa P, Watanaveeradej V, et al. Long-term neutralizing antibody response after a JE-CV single dose primary immunization in JE-vaccine na\u00efve toddlers. Presented at the 5th Asian Vaccine Conference (ASVAC); 2015 Jun 12\u201314; Hanoi, Vietnam"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.4161\/hv.23087"},{"key":"CIT0034","unstructured":"Chokephaibulkit K, Sabchareon A, Thisyakorn U, et al. Long-term neutralizing antibody response to a booster dose of a novel live-attenuated Japanese encephalitis vaccine (JE-CV - IMOJEV\u00ae) in a pediatric population. Presented at 7th Asian Congress of Pediatric Infectious Disease (ACPID); 2014 Oct 12\u201315; Beijing, China"},{"key":"CIT0035","unstructured":"Kim DS, Jang GC, Cha SH, et al. Immunogenicity and safety of a booster dose of IMOJEV\u00ae 12 months after a primary vaccination in Korean children. Presented at the 7th Annual Meeting of ACPID; 2014 Oct 12\u201315; Beijing, China. 2014."},{"key":"CIT0036","unstructured":"Kosalaraksa P, Wiangnon S, Suphakunpinyo C, et al. Booster effect of Japanese encephalitis chimerix virus vaccine (JE-CV): 5 years after primary vaccination. Presented at the 5th Asian Vaccine Conference (ASVAC); 2015 Jun 12\u201314; Hanoi, Vietnam"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000276"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29743"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.002"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-156"},{"key":"CIT0041","unstructured":"Feroldi E, Bailleux F, Monfredo C, et al. Modeling the long-term persistence of neutralizing antibodies after booster vaccination with a novel live attenuated Japanese encephalitis vaccine (JE-CV) \u2013 modeling Ab persistence in children. Presented at 8th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), 2013 Nov 19\u201322; Cape Town, South Africa"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14760584.2016.1123097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T22:46:24Z","timestamp":1692139584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14760584.2016.1123097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,9]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2,1]]}},"alternative-id":["10.1586\/14760584.2016.1123097"],"URL":"https:\/\/doi.org\/10.1586\/14760584.2016.1123097","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}